Shanghai, China

Huili He

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huili He: Innovator in Pharmaceutical Chemistry

Introduction

Huili He is a notable inventor based in Shanghai, China. She has made significant contributions to the field of pharmacy, particularly through her innovative work on benzoxazine oxazolidinone compounds. Her research focuses on developing novel compounds that can be used in the treatment of infectious diseases, especially those caused by multi-drug resistant bacteria.

Latest Patents

Huili He holds 1 patent for her invention titled "Benzoxazine oxazolidinone compounds, preparation methods and uses thereof." This patent discloses novel benzoxazine oxazolidinone compounds, along with their preparation methods and applications in creating medicaments for treating infectious diseases. The compounds are represented by a specific general formula and are aimed at addressing the challenges posed by resistant bacterial strains.

Career Highlights

Throughout her career, Huili He has worked with esteemed institutions such as the Chinese Academy of Sciences and Nanjing Changao Pharmaceutical Science & Technology Co., Limited. Her experience in these organizations has allowed her to advance her research and contribute to the pharmaceutical field significantly.

Collaborations

Huili He has collaborated with notable colleagues, including Yushe Yang and Qisheng Xin. These partnerships have further enriched her research endeavors and have facilitated the development of her innovative compounds.

Conclusion

Huili He is a pioneering inventor whose work in pharmaceutical chemistry is making strides in combating infectious diseases. Her contributions are vital in the ongoing battle against multi-drug resistant bacteria, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…